Bottle rockets cause permanent vision loss

Article

Bottle rocket injuries can cause serious ocular injury or permanent loss of vision in children and adolescents

Bottle rocket injuries can cause serious ocular injury or permanent loss of vision in children and adolescents, an investigation from the Archives of Ophthalmology has concluded.

The retrospective review, conducted by Ms Mehnaz Khan et al., Vanderbilt University School of Medicine, Nashville, Tennessee, USA, revealed several ocular injuries including corneal epithelial defect, hyphaema, traumatic iris, iridodialysis, cataract, retinal dialysis and vitreous haemorrhage.

Eleven eyes were used from 8 boys and 2 girls aged 5–17 years. The outcome measures consisted of present ocular injuries, interventions needed, the most recent visual acuity and the latest anatomic findings.

Four eyes underwent lensectomy, 2 eyes required corneal debridement, 1 eye required globe exploration and 1 eye needed retinal laser photocoagulation. Secondary interventions were required for 3 patients. This included 1 pars plana vitrectomy, 1 muscle surgery for sensory strabismus and 1 intraocular lens placement.

It was concluded that bottle rocket injuries resulted in permanent damage to vision commonly due to traumatic maculopathy.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.